Skip to main content
Figure 4 | Cardiovascular Diabetology

Figure 4

From: Anti-proliferative activity of oral anti-hyperglycemic agents on human vascular smooth muscle cells: thiazolidinediones (glitazones) have enhanced activity under high glucose conditions

Figure 4

Assessment of the cell cycle state of human vSMCs following treatment with clinical TZDs. S phase fraction in cultures treated with TZDs either Troglitazone, Rosiglitazone or Pioglitazone (1 μM each) in the presence of PDGF (50 ng/mL) for 24 h as compared with untreated controls. S phase fraction was analysed by flow cytometry using DNA staining with propidium iodide.

Back to article page